Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
| ▸ | PDE5A | O76074 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | GPX4 | P36969 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21648507 | 0.86 | MEN1 (0.55) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL21648509 | 0.86 | MEN1 (0.55) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL21648508 | 0.86 | MEN1 (0.55) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL23515571 | 0.78 | MEN1 (0.40) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL21648512 | 0.77 | MEN1 (0.43) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL21648513 | 0.77 | MEN1 (0.43) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL21648531 | 0.70 | MEN1 (0.58) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL21648546 | 0.70 | MEN1 (0.58) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL21648544 | 0.70 | MEN1 (0.58) | MEN1KMT2ATRPM8CYP19A1PDE5A | |
| SCHEMBL21648554 | 0.70 | MEN1 (0.53) | MEN1KMT2ATRPM8CYP19A1PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210179605-A1 | Discovery of Novel First in Class Nature-Inspired Compounds Targeting the Mitochondrial Function and Pharmaceutical Composition Thereof | UNIVERSITY OF SHARJAH (AE) | 2021-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179605-A1 | Discovery of Novel First in Class Nature-Inspired Compounds Targeting the Mitochondrial Function and Pharmaceutical Composition Thereof | NDUFAB1, TFAM, CS | MEN1 1244/4885KMT2A 4698/4885TRPM8 1487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.